Unicycive Therapeutics, Inc. - Common Stock, $0.001 par value (UNCY)

Historical Holders from Q2 2025 to Q3 2025

Type / Class
Equity / Common Stock, $0.001 par value
Symbol
UNCY on Nasdaq
Shares outstanding
17,543,860
Price per share
$4.36
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
6,285,927
Total reported value
$27,416,349
% of total 13F portfolios
0%
Share change
+1,141,789
Value change
+$4,969,639
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
30
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Unicycive Therapeutics, Inc. - Common Stock, $0.001 par value (UNCY) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Vivo Opportunity Fund Holdings, L.P. 10% $26,593,344 6,096,175 Vivo Opportunity Fund Holdings, L.P. 30 Sep 2025
RA CAPITAL MANAGEMENT, L.P. 9.9% $8,551,111 1,960,230 RA Capital Management, L.P. 30 Sep 2025
BIOTECHNOLOGY VALUE FUND L P 10% $6,022,747 1,417,117 BVF PARTNERS L P/IL 30 Jun 2025
Octagon Capital Advisors LP 5.7% -26% $4,362,300 1,000,000 0% Octagon Capital Advisors LP 30 Sep 2025
GREAT POINT PARTNERS LLC 4.5% -29% $3,474,825 796,558 0% Great Point Partners, LLC 30 Sep 2025
As of 30 Sep 2025, Unicycive Therapeutics, Inc. - Common Stock, $0.001 par value (UNCY) has 30 institutional shareholders filing 13F forms. They hold 6,285,927 shares. of 17,543,860 outstanding shares (36%) .

Top 25 institutional shareholders own 36% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
Vivo Capital, LLC 10% 1,789,916 +57% 0.63% $7,804,034
Octagon Capital Advisors LP 5.7% 1,000,000 0% 0.68% $4,360,000
Nantahala Capital Management, LLC 5.4% 939,202 0% 0.25% $4,094,921
GREAT POINT PARTNERS LLC 4.5% 796,558 0% 1.4% $3,472,993
VANGUARD GROUP INC 3.8% 658,878 +8.7% 0% $2,872,708
Logos Global Management LP 2.7% 473,563 +0% 0.2% $2,064,735
GEODE CAPITAL MANAGEMENT, LLC 0.72% 125,727 +114% 0% $548,168
Squarepoint Ops LLC 0.67% 117,327 0% $511,546
ACUTA CAPITAL PARTNERS, LLC 0.34% 59,985 -4.6% 0.27% $261,535
STATE STREET CORP 0.31% 54,827 +338% 0% $239,046
GOLDMAN SACHS GROUP INC 0.26% 45,200 0% $197,072
CITADEL ADVISORS LLC 0.24% 41,674 0% $181,699
XTX Topco Ltd 0.22% 37,823 0.01% $164,908
BlackRock, Inc. 0.21% 36,355 0% $158,508
NORTHERN TRUST CORP 0.19% 32,699 +203% 0% $142,568
Chicago Partners Investment Group LLC 0.15% 26,961 0% $127,256
Cubist Systematic Strategies, LLC 0.14% 23,947 0% $104,409
MORGAN STANLEY 0.06% 10,612 +961% 0% $46,268
CITIGROUP INC 0.04% 6,692 0% $29,177
UBS Group AG 0.03% 5,445 0% $23,740
BANK OF AMERICA CORP /DE/ 0% 827 +1192% 0% $3,606
SBI Securities Co., Ltd. 0% 560 +1.3% 0% $2,442
Rockefeller Capital Management L.P. 0% 500 0% $2,180
TFC Financial Management, Inc. 0% 300 0% $1,308
Fortitude Family Office, LLC 0% 107 0% $467

Institutional Holders of Unicycive Therapeutics, Inc. - Common Stock, $0.001 par value (UNCY) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q3 6,285,927 $27,416,349 +$4,969,639 436% 30
2025 Q2 5,144,083 $24,616,897 +$24,616,897 477% 19